-
Je něco špatně v tomto záznamu ?
Treatment of retinal capillary hemangioma using 810 nm infrared laser
P. Pochop, M. Kodetova, D. Dotrelova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
29765174
DOI
10.5507/bp.2018.019
Knihovny.cz E-zdroje
- MeSH
- dítě MeSH
- infračervené záření * terapeutické užití MeSH
- kapilární hemangiom komplikace terapie MeSH
- laserová terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- nádory sítnice * komplikace terapie MeSH
- pozorovací studie jako téma MeSH
- prospektivní studie MeSH
- Check Tag
- dítě MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIM: Presentation of the efficacy of infrared laser for the treatment of retinal capillary hemangioma (RCH). METHODS: The treatment and follow-up of nine eyes (fourteen tumors of different sizes and localizations) in seven patients (five children) with RCH. Infrared diode laser (810 nm) was used for modified transpupillary thermotherapy (TTT) in long exposition mode and power between 200 and 1200 mW with a beam diameter of 2 mm (indirect ophthalmoscope, +28 D or +40 D lens) or 0.5 mm-3 mm (slit-lamp) depending on the diameter and localisation of the hemangioma. RESULTS: We achieved complete destruction of the tumor with flat chorioretinal atrophic scar in all cases. Only one tumor regrowth was observed and re-treatment in this case was necessary. Treatment was combined with brachytherapy in a one case. There was one serious complication- total exudative retinal detachment, causing permanent deterioration in visual acuity despite pars plana vitrectomy (PPV). Other complications such as haze and vitreal hemorrhage were transient. The final best corrected visual acuity (BCVA) ranged from 20/20 to counting fingers at 2 feet. CONCLUSION: Infrared laser can be considered an acceptable therapeutic option for RCH especially for centrally localized lesions. We believe that the role of this therapy will increase in the future.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19011752
- 003
- CZ-PrNML
- 005
- 20230316094454.0
- 007
- ta
- 008
- 190404s2018 xr a f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2018.019 $2 doi
- 035 __
- $a (PubMed)29765174
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pochop, Pavel $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University, Prague and University Hospital Motol, Prague, Czech Republic. $7 xx0142580
- 245 10
- $a Treatment of retinal capillary hemangioma using 810 nm infrared laser / $c P. Pochop, M. Kodetova, D. Dotrelova
- 520 9_
- $a AIM: Presentation of the efficacy of infrared laser for the treatment of retinal capillary hemangioma (RCH). METHODS: The treatment and follow-up of nine eyes (fourteen tumors of different sizes and localizations) in seven patients (five children) with RCH. Infrared diode laser (810 nm) was used for modified transpupillary thermotherapy (TTT) in long exposition mode and power between 200 and 1200 mW with a beam diameter of 2 mm (indirect ophthalmoscope, +28 D or +40 D lens) or 0.5 mm-3 mm (slit-lamp) depending on the diameter and localisation of the hemangioma. RESULTS: We achieved complete destruction of the tumor with flat chorioretinal atrophic scar in all cases. Only one tumor regrowth was observed and re-treatment in this case was necessary. Treatment was combined with brachytherapy in a one case. There was one serious complication- total exudative retinal detachment, causing permanent deterioration in visual acuity despite pars plana vitrectomy (PPV). Other complications such as haze and vitreal hemorrhage were transient. The final best corrected visual acuity (BCVA) ranged from 20/20 to counting fingers at 2 feet. CONCLUSION: Infrared laser can be considered an acceptable therapeutic option for RCH especially for centrally localized lesions. We believe that the role of this therapy will increase in the future.
- 650 _7
- $a kapilární hemangiom $x komplikace $x terapie $7 D018324 $2 czmesh
- 650 17
- $a nádory sítnice $x komplikace $x terapie $7 D019572 $2 czmesh
- 650 17
- $a infračervené záření $x terapeutické užití $7 D007259 $2 czmesh
- 650 _7
- $a laserová terapie $7 D053685 $2 czmesh
- 650 _7
- $a prospektivní studie $7 D011446 $2 czmesh
- 650 _7
- $a pozorovací studie jako téma $7 D064887 $2 czmesh
- 650 _7
- $a dítě $7 D002648 $2 czmesh
- 650 _7
- $a lidé $7 D006801 $2 czmesh
- 650 _7
- $a lidé středního věku $7 D008875 $2 czmesh
- 650 _7
- $a mladiství $7 D000293 $2 czmesh
- 650 _7
- $a mladý dospělý $7 D055815 $2 czmesh
- 650 _7
- $a mužské pohlaví $7 D008297 $2 czmesh
- 650 _7
- $a ženské pohlaví $7 D005260 $2 czmesh
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kodetová, Martina $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University, Prague and University Hospital Motol, Prague, Czech Republic. $7 xx0252408
- 700 1_
- $a Dotřelová, Dagmar, $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University, Prague and University Hospital Motol, Prague, Czech Republic. $d 1950- $7 mzk2006356165
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 162, č. 4 (2018), s. 324-328
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29765174 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y a $z 0
- 990 __
- $a 20190404 $b ABA008
- 991 __
- $a 20230316094448 $b ABA008
- 999 __
- $a ok $b bmc $g 1390899 $s 1050057
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 162 $c 4 $d 324-328 $e 20180516 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $c NLK182 $d 20230316 $b NLK198 $a Pubmed-20190404